You don’t know what you are missing out on.

Let me tell you, the Clinical Trials Impact Africa summit was absolutely mind-blowing. I had the opportunity to attend this event, and let me tell you, it was an experience like no other. The summit was both eye-opening and exhilarating, and it’s only just begun.

One of the highlights of the summit was getting the chance to meet Mazi Sam Ohabunwa, an influential keynote speaker at the event. Sam Ohabunwa is a powerhouse in the pharmaceutical industry, and his insights were nothing short of awe-inspiring. He spoke about how our product for clinical trials was unjustly aborted by NAFDAC, due to their hostile fees.

It is absolutely outrageous that a regulatory authority would block potentially life-changing advancements in the medical field. NAFDAC’s hostile fees not only hinder the progress of clinical trials but also put a devastating halt to vital developments in medicine and healthcare. It’s a true shame to see bureaucracy and greed standing in the way of innovation and progress.

It’s clear that NAFDAC’s actions are not only detrimental to the advancement of healthcare in Africa but also to the potential improvement of the lives of countless individuals. The ripple effect of such actions is far-reaching and has serious consequences for the advancement of medicine in Africa.

The need for clinical trials in Africa is paramount, as it is essential for the development of new treatments and medications. If regulatory bodies continue to stifle these trials, the continent is at a severe disadvantage when it comes to advancements in healthcare. It’s time to put an end to the barriers and obstacles that prevent Africa from leading the way in medical innovation.

Furthermore, the Clinical Trials Impact Africa summit shed light on the importance of collaboration and partnership between pharmaceutical companies, regulatory agencies, and healthcare professionals. We must work together to overcome the challenges that currently impede the progress of clinical trials in Africa. Only through cooperation and commitment can we surmount the obstacles and pave the way for groundbreaking advancements in medicine.

It’s not enough to simply talk about the issues – we must take action to bring about real change. It is the responsibility of all stakeholders in the pharmaceutical and healthcare industry to advocate for fair and reasonable regulations that will enable the progress of clinical trials in Africa.

We must demand transparency and accountability from regulatory bodies such as NAFDAC, and ensure that they are acting in the best interests of the people and the future of healthcare in Africa.

The Clinical Trials Impact Africa summit has reignited my passion and determination to fight for change. We cannot continue to allow bureaucratic red tape and unjust practices to stifle the progress of clinical trials in Africa. It’s time to stand up and demand progress, innovation, and access to life-changing medical advancements for the people of Africa.

The summit was an incredibly galvanizing experience, and I am committed to driving forward the conversation about the importance of clinical trials in Africa. It’s time to make some noise and demand the changes that are long overdue. The future of healthcare in Africa depends on it.

The Impact Africa summit was a powerful catalyst for change, and it’s only just begun. It’s up to us to carry the torch forward, and to be the change agents that our continent needs. I am committed to playing my part, and I am calling on all of you to join me in this critical mission. Let’s come together and make our voices heard. It’s time to demand the change we deserve. Africa, it’s time to rise up.

Checkout all my current offers HERE


One of the highlights of the summit was getting the chance to meet Mazi Sam Ohabunwa, an influential keynote speaker at the event.

The need for clinical trials in Africa is paramount, as it is essential for the development of new treatments and medications. If regulatory bodies continue to stifle these trials, the continent is at a severe disadvantage when it comes to advancements in healthcare.

The Impact Africa summit was a powerful catalyst for change, and it's only just begun

Sam Ohabunwa is a powerhouse in the pharmaceutical industry, and his insights were nothing short of awe-inspiring. He spoke about how our product for clinical trials was unjustly aborted by NAFDAC, due to their hostile fees.

Leave a Reply